STAT Plus: Democrats are suddenly eyeing a valuable pharma asset: its patents
CHIP SOMODEVILLA/GETTY IMAGES
After a midterm election that saw voters more focused on drug prices than ever before, progressives are decrying pharma's abuses of the patent system.
.png)
No hay comentarios:
Publicar un comentario